Reporter and Contact
Name, affiliation, contact method, and reporter type (healthcare professional, consumer, manufacturer); include consent to release protected health information when required by HIPAA.
A complete, well-structured pharmacovigilance form speeds regulatory reporting, preserves forensic audit trails, and reduces queries from regulators. It protects patient privacy, supports safety signal detection, and documents company compliance with applicable U.S. reporting obligations and internal standard operating procedures.
The Healthcare Pharmacovigilance Activities Form is used across regulated safety workflows where accurate, auditable adverse-event documentation is required.
Teams completing and signing the form must understand their regulatory role, applicable privacy rules, and internal escalation timelines.
Oversees case intake, validation, classification, and regulatory submission. Ensures completeness of clinical data and that follow-up queries are issued and tracked until closure; coordinates cross-functional review when necessary.
Provides the original event narrative, clinical findings, and treatment/outcome details. The clinician must confirm patient identifiers and relevant medical history and be available for follow-up clarification when requested by safety staff.
Name, affiliation, contact method, and reporter type (healthcare professional, consumer, manufacturer); include consent to release protected health information when required by HIPAA.
Non-identifying demographic fields plus a secure link to the medical record or unique case ID; follow internal privacy rules to avoid unnecessary PHI exposure.
Product name, lot/batch, dosage, route, start/stop dates, and concomitant medications or devices relevant to causality assessment.
Clear chronology of onset, signs, symptoms, diagnostic findings, and clinical interventions; include severity grading and hospitalization status if applicable.
Clinical assessment of causality, seriousness criteria, outcome (recovered, ongoing, fatal), and any corrective actions taken or recommended.
Internal triage decision, expedited reporting indicators, submission timestamps, and an audit trail covering user, IP, and signature metadata for compliance.
| Field | Configuration |
|---|---|
| Authentication Method | Email link, SMS code, or enterprise SSO depending on risk. |
| Field Validation | Require date format, numeric ranges, and mandatory event fields. |
| Conditional Fields | Show follow-up questions only when seriousness criteria are checked. |
| Retention Setting | Apply secure archival policy aligned to HIPAA and company retention schedules. |
Choose tools that support secure file formats, robust authentication, and integration with safety databases and EHRs.
Notify safety team within 24–48 hours of learning about a serious event.
Prepare for regulatory expedited windows (commonly 7–15 days depending on severity and jurisdiction).
Submit additional information as it becomes available, typically within 30 days of initial report.
Adhere to scheduled periodic reports required by regulators and MAH obligations.
Define internal SLAs for triage, case entry, and sign-off to ensure timeliness.
A hospital pharmacovigilance unit used the form to standardize reporting across 12 departments
A pharma safety team deployed a digital intake template for investigator reports
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Varies by vendor | Varies by vendor | Varies by vendor | Varies by vendor |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | Varies by plan | Varies by plan |
| Envelope Cap | No cap | 100 envelopes/user/year | Varies by plan | Varies by plan | Varies by plan |